WayBetter
PrivateLast Round
Grant
Apr 15, 2020
Est. Valuation
$15.42M
Total Funding Raised
$27.11M
Company Overview
WayBetter operates in Consumer & Commerce and is based in New York City, New York. Its latest recorded funding round was a Grant round in April 2020.
WayBetter is a health and wellness technology company that provides a social gaming platform to help users achieve their health and fitness goals through behavioral science, gamification, and financial incentives.
Sector
Consumer & Commerce
Verticals
Sports & Fitness, Subscription Commerce, Wagering Platforms
Business Model
B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WayBetter Comparables
Compare WayBetter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Appex | 82% | |
| Cadoo Inc. | 81% | |
| Nudge Healthcare | 78% |
For institutional investors. Book with your work email.
WayBetter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2020 | ||||
| Grant | Dec 1, 2019 | ||||
| Series B | May 1, 2016 | ||||
| Corporate Funding | Oct 6, 2015 | ||||
| Series A Extension | Oct 1, 2015 | ||||
Series A | Aug 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
WayBetter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ASICS Ventures Corporation | Grant |
| Kima Ventures | Series A |
| National Institute on Drug Abuse | Grant |
| NIH RADx | Grant |
| SeedInvest | Series A, Series B, Seed |
| Wilson Sonsini Goodrich & Rosati | Series A |
| Sparx Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 108% MoM, reaching 17.4K.
For institutional investors. Book with your work email.
WayBetter Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WayBetter's valuation, stock price, and market status.
Is WayBetter a public or private company?
WayBetter is a private company.
What is the current stock price of WayBetter?
WayBetter is a private company, so its shares have no public market price. Caplight tracks WayBetter's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WayBetter worth (valuation)?
WayBetter's valuation is estimated at $15.4M based on funding round data.
Can I buy WayBetter stock?
WayBetter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WayBetter's last funding round?
WayBetter's most recent funding round was Grant on April 15, 2020.
Who are the main investors in WayBetter?
Key investors in WayBetter include ASICS Ventures Corporation, ASICS TenKan-Ten Growth Catalyst, National Institute on Drug Abuse.
Will WayBetter IPO soon?
No public IPO plans have been announced for WayBetter.
How can I track WayBetter secondary market activity?
Caplight tracks bids, offers, and trades in WayBetter's shares on secondary markets.